glp-1 obesity drug news today oct 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Alarming rise in weight loss

Made in the USA in a GMP-certified facility, our GLP-1 supplement undergo strict testing to ensure they are 100% pure, potent, and effective

There are signs, however, that the landscape may be shifting

Why are patients with diabetes more prone to atrial fibrillation

While I understand that this action may concern some people, the risk of not acting is far greater

[7] who conducted a study to detect the risk of biliary-related diseases in patients with T2D using GLP-1RAs versus sodium glucose co-transporters 2 inhibitors (SGLT2I)

After observing weight-loss in T2D patients, a once-daily injection of liraglutide (Novo Nordisks Saxenda) was approved for obesity in 2014